Supernus Pharmaceuticals, Inc

(NASDAQ:SUPN)

Latest On Supernus Pharmaceuticals, Inc (SUPN):

Date/Time Type Description Signal Details
2023-05-10 07:37 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) Q1 2023 Earnings Call TranscriptN/A
2023-05-09 18:39 ESTNewsSupernus Pharmaceuticals GAAP EPS of $0.29 beats by $0.55, revenue of $153.8M beats by $14.78MN/A
2023-05-09 04:36 ESTNewsSupernus Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-04-04 20:51 ESTNewsSupernus Pharmaceuticals pays out $402M senior convertible notesN/A
2023-03-01 01:40 ESTNewsSupernus Pharmaceuticals reports Q4 results, sees FY 2023 revenue in-lineN/A
2023-03-01 01:40 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) Q4 2022 Earnings Call TranscriptN/A
2023-02-27 20:04 ESTNewsSupernus Pharmaceuticals Q4 2022 Earnings PreviewN/A
2023-02-15 02:54 ESTNewsSupernus secures $150M line of credit from UBS Bank USAN/A
2023-02-10 18:44 ESTNewsSupernus: Earnings YearningsN/A
2022-11-30 06:36 ESTNewsSupernus Pharmaceuticals: Shares Could Get CheapN/A
2022-11-08 19:34 ESTNewsSupernus Pharmaceuticals GAAP EPS of $0.03 misses by $0.33, revenue of $177.35M beats by $4.87MN/A
2022-11-08 19:34 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) Q3 2022 Earnings Call TranscriptN/A
2022-11-08 01:06 ESTNewsSupernus Pharmaceuticals Q3 2022 Earnings PreviewN/A
2022-10-10 17:31 ESTNewsSupernus stock falls 12.6% after FDA declines to approve Parkinson’s disease treatmentN/A
2022-09-10 04:18 ESTNewsSupernus Pharmaceuticals (SUPN) Investor Presentation - SlideshowN/A
2022-08-20 11:47 ESTNewsSupernus Pharmaceuticals: Deep Expertise In CNS, Eyes On Qelbree Launch And Parkinson PortfolioN/A
2022-08-07 11:02 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-04 17:16 ESTNewsSupernus Pharmaceuticals GAAP EPS of $0.14 misses by $0.15, revenue of $170.05M beats by $5.82MN/A
2022-08-04 02:17 ESTNewsSupernus Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-07-29 04:48 ESTNewsSupernus: A Work In ProgressN/A
2022-05-10 14:29 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-09 17:15 ESTNewsSupernus Pharmaceuticals GAAP EPS of $0.43 misses by $0.02, revenue of $152.51M beats by $2.04MN/A
2022-05-07 08:04 ESTNewsSupernus Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-05-02 09:21 ESTNewsSupernus rises on FDA label expansion of ADHD therapyN/A
2022-04-13 23:14 ESTNewsSupernus Pharmaceuticals GAAP EPS of $0.04 misses by $0.20, revenue of $159.05M in-lineN/A
2022-04-04 23:36 ESTNewsSupernus Pharmaceuticals drops 2.7% on 2022 guidanceN/A
2022-03-29 12:05 ESTNewsSupernus: New BeginningsN/A
2022-03-17 23:24 ESTNewsSupernus Pharmaceuticals notifies Nasdaq regarding non-compliance with listing ruleN/A
2022-03-01 13:25 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-28 00:52 ESTNewsSupernus Pharmaceuticals Q4 2021 Earnings PreviewN/A
2021-12-02 05:34 ESTNewsSupernus Pharma resumed Buy at Jefferies citing Adamas acquisitionN/A
2021-11-27 01:18 ESTNewsJasper more than doubles while M&A headlines weekly healthcare performersN/A
2021-11-04 16:57 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-03 19:31 ESTNewsSupernus Pharmaceuticals EPS beats by $0.17, beats on revenue; updates full year guidanceN/A
2021-11-03 19:30 ESTNewsSupernus up 10% following 2021 earnings guidance boost, Q3 beatN/A
2021-11-02 23:54 ESTNewsSupernus Pharmaceuticals Q3 2021 Earnings PreviewN/A
2021-10-27 03:49 ESTNewsAdamas Pharmaceuticals: An Acceptable Buyout At The Perfect TimeN/A
2021-10-11 18:00 ESTNewsSupernus to acquire Adamas in a deal worth up to $850 millionN/A
2021-10-11 17:59 ESTNewsAs Supernus acquires Adamas, other Parkinson's players mixed on the dayN/A
2021-09-03 02:57 ESTNewsFDA accepts for review Supernus' Qelbree sNDA for ADHD in adultsN/A
2021-08-26 01:08 ESTNewsSupernus: Well Prepared For Upcoming ChallengesN/A
2021-08-05 13:54 ESTNewsSupernus Pharmaceuticals EPS beats by $0.23, beats on revenueN/A
2021-08-05 13:53 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-03 19:03 ESTNewsSupernus Pharmaceuticals Q2 2021 Earnings PreviewN/A
2021-07-30 21:28 ESTNewsSupernus Pharma appoints Opgen executive as new CFON/A
2021-07-22 02:11 ESTNewsSupernus Pharma inks supply agreement with Bachem for key ingredient in ADHD drugN/A
2021-05-05 23:52 ESTNewsSupernus Pharmaceuticals EPS misses by $0.11, beats on revenue; reaffirms guidanceN/A
2021-05-05 23:51 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q1 2021 Results - Earnings Call TranscriptN/A
2021-05-05 03:39 ESTNewsSupernus Pharmaceuticals Q1 2021 Earnings PreviewN/A
2021-04-13 20:31 ESTNewsIRhythm extends losses as more downgrades pile up, Aphria cut to neutral after earnings miss; and more in today’s analyst actionN/A

About Supernus Pharmaceuticals, Inc (SUPN):

Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. Its commercial products include Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prophylaxis of migraine headache; and Oxtellar XR, an extended release oxcarbazepine for the monotherapy treatment of partial onset epilepsy seizures in adults and children between 6 to 17 years of age. The company's commercial products also comprise APOKYN, a product indicated for the acute intermittent treatment of hypomobility or off episodes in patients with advanced Parkinson's Disease (PD); XADAGO, a product indicated as adjunctive treatment to levodopa/carbidopa in patients with PD experiencing off episodes; and MYOBLOC, a Type B toxin product indicated for the treatment of cervical dystonia and sialorrhea in adults. In addition, its product candidates include SPN-812, which has completed Phase III clinical trials that is used for the treatment of attention deficit hyperactivity disorder (ADHD); SPN-830, a late-stage drug/device combination product candidate for the prevention of off episodes in PD; SPN-817, a novel product candidate in Phase I clinical trials for the treatment of severe epilepsy; and SPN-820, a novel product candidate in Phase I clinical trials for treatment resistant depression. The company markets and sells its products through pharmaceutical wholesalers, specialty pharmacies, and distributors. It has a development and option agreement with Navitor Pharmaceuticals, Inc. to conduct a Phase II clinical program for NV-5138 in treatment-resistant depression. The company was founded in 2005 and is headquartered in Rockville, Maryland.

See Advanced Chart

General

  • Name Supernus Pharmaceuticals, Inc
  • Symbol SUPN
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 563
  • Fiscal Year EndDecember
  • IPO Date2012-05-01
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.supernus.com
View More

Valuation

  • Trailing PE 11.12
  • Forward PE 20.16
  • Price/Sales (Trailing 12 Mt.) 2.76
  • Price/Book (Most Recent Quarter) 1.9
  • Enterprise Value Revenue 2.66
  • Enterprise Value EBITDA 6.58
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $1.02
  • Next Year EPS Estimate $1.24
  • Next Quarter EPS Estimate $0.40
  • Profit Margin 24%
  • Operating Margin 36%
  • Return on Assets 9%
  • Return on Equity 19%
  • Revenue 520.4 million
  • Earnings Per Share $2.36
  • Revenue Per Share $9.89
  • Gross Profit 467.94 million
  • Quarterly Earnings Growth 42.9%
View More

Highlights

  • Market Capitalization 1.39 billion
  • EBITDA 206.24 million
  • PE Ratio 369.82
  • PEG Ratio 1.47
  • Analyst Target Price $30.75
  • Book Value Per Share $14.09
View More

Share Statistics

  • Shares Outstanding 52.92 million
  • Shares Float 47.91 million
  • % Held by Insiders 361%
  • % Held by Institutions 101.46%
  • Shares Short 7.47 million
  • Shares Short Prior Month 7.15 million
  • Short Ratio 14.42
  • Short % of Float 21%
  • Short % of Shares Outstanding 14%
View More

Technicals

  • Beta 1.29
  • 52 Week High $31.99
  • 52 Week Low $15.58
  • 50 Day Moving Average 28.34
  • 200 Day Moving Average 24.03
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Supernus Pharmaceuticals, Inc (SUPN) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Supernus Pharmaceuticals, Inc (SUPN) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A$0.57$0.4916.33%
2020-09-302020-11-03$155.14 million$0.74$0.27170.76%
2020-06-302020-08-17$126.73 million$0.65$0.4254.76%
2020-03-312020-05-05$N/A$0.40$0.2653.85%
2019-12-312020-02-25$100.45 million$0.62$0.595.8%
2019-09-302019-11-05$102.14 million$0.54$0.59-8.47%
2019-06-302019-08-06$104.7 million$0.61$0.601.24%
2019-03-312019-05-07$85.47 million$0.34$0.47-26.88%
2018-12-312019-02-26$115.93 million$0.48$0.2967.19%
2018-09-302018-11-06$103 million$0.52$0.4222.93%
2018-06-302018-08-07$99.54 million$0.57$0.4526.67%
2018-03-312018-05-08$90.43 million$0.49$0.3251.94%
2017-12-312018-02-27$88.44 million$0.26$0.28-7.6%
2017-09-302017-11-06$80.4 million$0.30$0.286.71%
2017-06-302017-08-02$75.83 million$0.33$0.2436.5%
2017-03-312017-05-09$57.58 million$0.19$0.25-24%
2016-12-312017-01-20$62.37 million$0.37$0.347.19%
2016-09-302016-09-30$56.81 million$1.18$0.34247.06%
2016-06-302016-08-02$51.63 million$0.18$0.1336.67%
2016-03-312016-05-04$44.19 million$0.10$0.0913.8%
2015-12-312016-03-02$43.69 million$0.14$0.06128.83%
2015-09-302015-11-03$39.36 million$0.08$0.02300%
2015-06-302015-08-04$35.68 million$0.03$0.0250%
2015-03-312015-05-05$28.74 million$0.02-$0.01300%
2014-12-312015-03-10$31.24 million$0.10-$0.12183.33%
2014-09-302014-11-11$52.49 million$0.39$0.368.33%
2014-06-302014-08-11$29.68 million$0.08-$0.15153.33%
2014-03-312014-05-12$9.08 million-$0.35-$0.4114.63%
2013-12-312014-03-12$10.34 million-$0.39-$0.5529.09%
2013-09-302013-11-12$1.26 million-$0.64-$0.674.48%
2013-06-302013-08-13$281000-$0.57-$0.6512.31%
2013-03-312013-05-13$147000-$0.60-$0.7115.49%
2012-12-312013-03-14$1.09 million-$0.51-$0.7128.17%
2012-09-302012-11-07$92000-$0.55-$0.6211.29%
2012-06-302012-08-10$91000-$0.61-$0.48-27.08%
2012-03-312012-06-07$208000-$0.42

Supernus Pharmaceuticals, Inc (SUPN) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Supernus Pharmaceuticals, Inc (SUPN) Chart:

Supernus Pharmaceuticals, Inc (SUPN) News:

Below you will find a list of latest news for Supernus Pharmaceuticals, Inc (SUPN) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Supernus Pharmaceuticals, Inc (SUPN) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-04-17200CALL0 0106.73TRUE00
2025-04-17250CALL0 066.76TRUE00
2025-04-17260CALL0 062.28TRUE00
2025-04-17270CALL0 065.63TRUE00
2025-04-17280CALL0 038.06TRUE00
2025-04-17290CALL0 054.89TRUE00
2025-04-17300CALL0 028.11TRUE00
2025-04-17310CALL0 052.41TRUE00
2025-04-17320CALL0 049.83TRUE00
2025-04-17330CALL0 053.48FALSE00
2025-04-17340.75CALL0 259.3FALSE00
2025-04-17350CALL0 063.48FALSE00
2025-04-17361.5CALL0 237.07FALSE00
2025-04-17370CALL0 079.97FALSE00
2025-04-17380CALL0 083.83FALSE00
2025-04-17390CALL0 093.36FALSE00
2025-04-17400CALL0 098.95FALSE00
2025-04-17410CALL0 0105.1FALSE00
2025-04-17420CALL0 078.29FALSE00
2025-04-17430CALL0 0115.58FALSE00
2025-04-17440CALL0 0120.93FALSE00
2025-04-17450CALL0 0117.59FALSE00
2025-04-17460CALL0 0131.01FALSE00
2025-04-17470CALL0 0135.77FALSE00
2025-04-17480CALL0 0140.36FALSE00
2025-04-17200PUT0 0171.57FALSE00
2025-04-17250PUT0 082.07FALSE00
2025-04-17260PUT0 072.6FALSE00
2025-04-17270PUT0 055.81FALSE00
2025-04-17280PUT0 088.68FALSE00
2025-04-17290.61PUT0 277.64FALSE00
2025-04-17300PUT0 066.32FALSE00
2025-04-17310PUT0 056.77FALSE00
2025-04-17320PUT0 046.65FALSE00
2025-04-17330PUT0 045.16TRUE00
2025-04-17342.7PUT0 260.6TRUE00
2025-04-17352.05PUT0 149.28TRUE00
2025-04-17360PUT0 030.72TRUE00
2025-04-17370PUT0 040.1TRUE00
2025-04-17380PUT0 041.33TRUE00
2025-04-17390PUT0 0127.5TRUE00
2025-04-17400PUT0 0121.65TRUE00
2025-04-17410PUT0 0141.5TRUE00
2025-04-17420PUT0 059.66TRUE00
2025-04-17430PUT0 00TRUE00
2025-04-17440PUT0 067.82TRUE00
2025-04-17450PUT0 0162.46TRUE00
2025-04-17460PUT0 075.45TRUE00
2025-04-17470PUT0 079.1TRUE00
2025-04-17480PUT0 00TRUE00
2025-05-16240CALL0 062.07TRUE00
2025-05-16250CALL0 065.79TRUE00
2025-05-16260CALL0 058.43TRUE00
2025-05-16270CALL0 052.87TRUE00
2025-05-16280CALL0 058.32TRUE00
2025-05-16290CALL0 051.46TRUE00
2025-05-16300CALL0 048.35TRUE00
2025-05-16310CALL0 048.54TRUE00
2025-05-16320CALL0 050.9TRUE00
2025-05-16330CALL0 041.85FALSE00
2025-05-16340CALL0 049.66FALSE00
2025-05-16350CALL0 051.39FALSE00
2025-05-16360CALL0 054.89FALSE00
2025-05-16370CALL0 058.86FALSE00
2025-05-16380CALL0 040.9FALSE00
2025-05-16390CALL0 064.78FALSE00
2025-05-16400CALL0 068.68FALSE00
2025-05-16240PUT0 084FALSE00
2025-05-16250PUT0 081.79FALSE00
2025-05-16260PUT0 079.59FALSE00
2025-05-16270PUT0 074.65FALSE00
2025-05-16280PUT0 065.56FALSE00
2025-05-16290PUT0 059.55FALSE00
2025-05-16300PUT0 055.39FALSE00
2025-05-16310PUT0 044.13FALSE00
2025-05-16320PUT0 042.67FALSE00
2025-05-16330PUT0 056.36TRUE00
2025-05-16340PUT0 040.87TRUE00
2025-05-16350PUT0 042.77TRUE00
2025-05-16360PUT0 040.48TRUE00
2025-05-16370PUT0 058.9TRUE00
2025-05-16380PUT0 043.34TRUE00
2025-05-16390PUT0 080.64TRUE00
2025-05-16400PUT0 068.84TRUE00
2025-06-202012.7CALL2 870.87TRUE12.70
2025-06-20258CALL0 10163.01TRUE00
2025-06-20260CALL0 041.61TRUE00
2025-06-20270CALL0 040.37TRUE00
2025-06-20280CALL0 029.49TRUE00
2025-06-20290CALL0 040.61TRUE00
2025-06-203010CALL0 342.22TRUE00
2025-06-20313.27CALL0 843.42TRUE00
2025-06-20320CALL0 042.37TRUE00
2025-06-20330CALL0 048.31FALSE00
2025-06-20340CALL0 037.22FALSE00
2025-06-20352.04CALL0 337.39FALSE00
2025-06-20361.05CALL0 736.2FALSE00
2025-06-20370.74CALL0 5341.82FALSE00
2025-06-20381.45CALL0 343.48FALSE00
2025-06-20391.3CALL0 1153.31FALSE00
2025-06-20401.05CALL0 8355.52FALSE00
2025-06-20413.3CALL0 2657.96FALSE00
2025-06-20450.85CALL0 1467.91FALSE00
2025-06-20501.55CALL0 679.27FALSE00
2025-06-20550.75CALL0 284.71FALSE00
2025-06-20600.55CALL0 199.12FALSE00
2025-06-20200.55PUT0 493.23FALSE00
2025-06-20250.85PUT0 769.47FALSE00
2025-06-20260.6PUT1 646.71FALSE0.60
2025-06-20271.25PUT0 457.41FALSE00
2025-06-20281.45PUT0 553.41FALSE00
2025-06-20291PUT0 247.72FALSE00
2025-06-20301.75PUT0 1240.52FALSE00
2025-06-20312.05PUT0 239.43FALSE00
2025-06-20321.9PUT0 1444.58FALSE00
2025-06-20332.55PUT0 3735.2TRUE00
2025-06-20343.2PUT0 139.49TRUE00
2025-06-20354PUT0 740.13TRUE00
2025-06-20360PUT0 037.7TRUE00
2025-06-20374.7PUT0 134.17TRUE00
2025-06-20385PUT0 137.95TRUE00
2025-06-20390PUT0 037.86TRUE00
2025-06-20400PUT0 042.42TRUE00
2025-06-20410PUT0 041.18TRUE00
2025-06-20450PUT0 087.38TRUE00
2025-06-20500PUT0 00TRUE00
2025-06-20550PUT0 065.37TRUE00
2025-06-20600PUT0 00TRUE00
2025-09-19200CALL0 064.44TRUE00
2025-09-19250CALL0 043.54TRUE00
2025-09-19300CALL0 042.33TRUE00
2025-09-193110.1CALL0 142.66TRUE00
2025-09-19320CALL0 041.92TRUE00
2025-09-19333.1CALL0 141.31FALSE00
2025-09-19342CALL0 344.71FALSE00
2025-09-19352.1CALL0 641.04FALSE00
2025-09-19360CALL0 041.69FALSE00
2025-09-19371.75CALL0 143.11FALSE00
2025-09-19381.45CALL0 1842.49FALSE00
2025-09-19391.3CALL0 442.41FALSE00
2025-09-19400.9CALL0 1444.8FALSE00
2025-09-19412CALL0 144.82FALSE00
2025-09-19420.65CALL0 1145.89FALSE00
2025-09-19431.35CALL0 147.13FALSE00
2025-09-19440CALL0 047.16FALSE00
2025-09-19451.3CALL0 149.91FALSE00
2025-09-19460CALL0 051.13FALSE00
2025-09-19500.25CALL0 557.06FALSE00
2025-09-19551.55CALL0 263.85FALSE00
2025-09-19601.05CALL0 365.33FALSE00
2025-09-19200.19PUT0 272.19FALSE00
2025-09-19250.8PUT0 252.64FALSE00
2025-09-19301.65PUT0 242.84FALSE00
2025-09-19311.5PUT0 139.78FALSE00
2025-09-19321.75PUT0 138.39FALSE00
2025-09-19334.14PUT0 238.78TRUE00
2025-09-19343.6PUT0 137.54TRUE00
2025-09-19354.2PUT0 436.91TRUE00
2025-09-19364.8PUT0 237.8TRUE00
2025-09-19370PUT0 033.34TRUE00
2025-09-19380PUT0 037.05TRUE00
2025-09-19390PUT0 038.62TRUE00
2025-09-19400PUT0 037.06TRUE00
2025-09-19418.1PUT0 240.31TRUE00
2025-09-19420PUT0 041.1TRUE00
2025-09-19430PUT0 056.31TRUE00
2025-09-19440PUT0 051.75TRUE00
2025-09-19450PUT0 050.93TRUE00
2025-09-19460PUT0 037.94TRUE00
2025-09-19500PUT0 00TRUE00
2025-09-19550PUT0 069.07TRUE00
2025-09-19600PUT0 00TRUE00

Latest SUPN Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$26.54
Jun 13, 2022 7:59 PM EST78$26.52
Jun 13, 2022 7:59 PM EST12$26.53
Jun 13, 2022 7:59 PM EST100$26.52
Jun 13, 2022 7:59 PM EST113$26.54

Supernus Pharmaceuticals, Inc (SUPN) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000044/0001356576-20-000044-index.htm
2018-09-21UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1356576/000000000018029835/0000000000-18-029835-index.htm
2018-11-02UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1356576/000000000018034262/0000000000-18-034262-index.htm
2018-12-07UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1356576/000000000018037479/0000000000-18-037479-index.htm
2019-07-17UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1356576/000000000019011207/0000000000-19-011207-index.htm
2019-08-07UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1356576/000000000019012145/0000000000-19-012145-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1356576/000021545719007287/0000215457-19-007287-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1356576/000083423720008681/0000834237-20-008681-index.htm
2020-03-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1356576/000091957420002390/0000919574-20-002390-index.htm
2019-01-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1356576/000093247119001355/0000932471-19-001355-index.htm
2019-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1356576/000104746919000828/0001047469-19-000828-index.htm
2019-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1356576/000104746919002684/0001047469-19-002684-index.htm
2018-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000110465918032082/0001104659-18-032082-index.htm
2018-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918032502/0001104659-18-032502-index.htm
2018-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918033849/0001104659-18-033849-index.htm
2018-05-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918034093/0001104659-18-034093-index.htm
2018-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918037201/0001104659-18-037201-index.htm
2018-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918039860/0001104659-18-039860-index.htm
2018-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918041086/0001104659-18-041086-index.htm
2018-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918041853/0001104659-18-041853-index.htm
2018-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918043279/0001104659-18-043279-index.htm
2018-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918043589/0001104659-18-043589-index.htm
2018-07-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918043595/0001104659-18-043595-index.htm
2018-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918043597/0001104659-18-043597-index.htm
2018-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918043825/0001104659-18-043825-index.htm
2018-07-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918047769/0001104659-18-047769-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918050207/0001104659-18-050207-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000110465918050920/0001104659-18-050920-index.htm
2018-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918055089/0001104659-18-055089-index.htm
2018-09-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918055660/0001104659-18-055660-index.htm
2018-09-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918057416/0001104659-18-057416-index.htm
2018-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918057845/0001104659-18-057845-index.htm
2018-10-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1356576/000110465918060747/0001104659-18-060747-index.htm
2018-10-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918063964/0001104659-18-063964-index.htm
2018-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918066367/0001104659-18-066367-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918066998/0001104659-18-066998-index.htm
2018-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000110465918067217/0001104659-18-067217-index.htm
2018-11-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1356576/000110465918069011/0001104659-18-069011-index.htm
2018-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918072139/0001104659-18-072139-index.htm
2018-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918073844/0001104659-18-073844-index.htm
2018-12-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918074466/0001104659-18-074466-index.htm
2019-01-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919002327/0001104659-19-002327-index.htm
2019-02-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919005844/0001104659-19-005844-index.htm
2019-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919007979/0001104659-19-007979-index.htm
2019-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010743/0001104659-19-010743-index.htm
2019-02-265Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010791/0001104659-19-010791-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010794/0001104659-19-010794-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010795/0001104659-19-010795-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010796/0001104659-19-010796-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010797/0001104659-19-010797-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010798/0001104659-19-010798-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010799/0001104659-19-010799-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010800/0001104659-19-010800-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010801/0001104659-19-010801-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010802/0001104659-19-010802-index.htm
2019-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919011559/0001104659-19-011559-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919012547/0001104659-19-012547-index.htm
2019-03-044/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919012549/0001104659-19-012549-index.htm
2019-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919013142/0001104659-19-013142-index.htm
2019-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919016356/0001104659-19-016356-index.htm
2019-03-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919018296/0001104659-19-018296-index.htm
2019-04-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919019961/0001104659-19-019961-index.htm
2019-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919023424/0001104659-19-023424-index.htm
2019-04-25SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1356576/000110465919023500/0001104659-19-023500-index.htm
2019-04-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919024504/0001104659-19-024504-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919027555/0001104659-19-027555-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000110465919028593/0001104659-19-028593-index.htm
2019-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919033130/0001104659-19-033130-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919037264/0001104659-19-037264-index.htm
2019-07-31CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1356576/000110465919043062/0001104659-19-043062-index.htm
2019-08-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919043393/0001104659-19-043393-index.htm
2019-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919047536/0001104659-19-047536-index.htm
2019-12-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919076466/0001104659-19-076466-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920017388/0001104659-20-017388-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024846/0001104659-20-024846-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024847/0001104659-20-024847-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024848/0001104659-20-024848-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024849/0001104659-20-024849-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024850/0001104659-20-024850-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024851/0001104659-20-024851-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024852/0001104659-20-024852-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024853/0001104659-20-024853-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024891/0001104659-20-024891-index.htm
2020-02-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024913/0001104659-20-024913-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024915/0001104659-20-024915-index.htm
2020-02-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024919/0001104659-20-024919-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024920/0001104659-20-024920-index.htm
2020-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465920026188/0001104659-20-026188-index.htm
2020-03-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920037450/0001104659-20-037450-index.htm
2020-04-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920050721/0001104659-20-050721-index.htm
2020-04-24DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1356576/000110465920050722/0001104659-20-050722-index.htm
2020-05-04DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1356576/000110465920056047/0001104659-20-056047-index.htm
2020-05-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920059729/0001104659-20-059729-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920064386/0001104659-20-064386-index.htm
2020-06-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920077403/0001104659-20-077403-index.htm
2020-07-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920083086/0001104659-20-083086-index.htm
2020-07-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920083754/0001104659-20-083754-index.htm
2020-07-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920087366/0001104659-20-087366-index.htm
2020-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920100179/0001104659-20-100179-index.htm
2020-10-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920114365/0001104659-20-114365-index.htm
2020-10-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920114367/0001104659-20-114367-index.htm
2020-10-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920115378/0001104659-20-115378-index.htm
2020-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920122611/0001104659-20-122611-index.htm
2019-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000010/0001356576-19-000010-index.htm
2019-07-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000015/0001356576-19-000015-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000019/0001356576-19-000019-index.htm
2019-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000135657619000025/0001356576-19-000025-index.htm
2019-08-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000030/0001356576-19-000030-index.htm
2019-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000033/0001356576-19-000033-index.htm
2019-10-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000041/0001356576-19-000041-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000043/0001356576-19-000043-index.htm
2019-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000135657619000045/0001356576-19-000045-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000047/0001356576-19-000047-index.htm
2019-12-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000049/0001356576-19-000049-index.htm
2020-01-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000002/0001356576-20-000002-index.htm
2020-01-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000004/0001356576-20-000004-index.htm
2020-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000006/0001356576-20-000006-index.htm
2020-02-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1356576/000135657620000010/0001356576-20-000010-index.htm
2020-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000015/0001356576-20-000015-index.htm
2020-04-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000018/0001356576-20-000018-index.htm
2020-04-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000020/0001356576-20-000020-index.htm
2020-05-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000023/0001356576-20-000023-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000025/0001356576-20-000025-index.htm
2020-05-12NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000029/0001356576-20-000029-index.htm
2020-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000135657620000031/0001356576-20-000031-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000033/0001356576-20-000033-index.htm
2020-05-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000035/0001356576-20-000035-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000037/0001356576-20-000037-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000041/0001356576-20-000041-index.htm
2020-06-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000044/0001356576-20-000044-index.htm
2020-08-11NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000048/0001356576-20-000048-index.htm
2020-08-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000050/0001356576-20-000050-index.htm
2020-08-1710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000135657620000054/0001356576-20-000054-index.htm
2020-08-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000056/0001356576-20-000056-index.htm
2020-08-248-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000059/0001356576-20-000059-index.htm
2020-09-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000062/0001356576-20-000062-index.htm
2020-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000064/0001356576-20-000064-index.htm
2020-09-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000066/0001356576-20-000066-index.htm
2020-10-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000068/0001356576-20-000068-index.htm
2020-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000070/0001356576-20-000070-index.htm
2020-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000072/0001356576-20-000072-index.htm
2020-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000135657620000076/0001356576-20-000076-index.htm
2018-11-30CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1356576/999999999718009168/9999999997-18-009168-index.htm

Supernus Pharmaceuticals, Inc (SUPN) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Supernus Pharmaceuticals, Inc (SUPN). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 361%
Institutional Ownership: 10146%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-06-29Padmanabh P. BhattSr. VP of IP, CSOSell4,393.0059.90263,153.000.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918043279/0001104659-18-043279-index.htm
2020-02-21Frederick M. HudsonDirectorBuy5,211.0023.99125,011.8910,211.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920024852/0001104659-20-024852-index.htm
2018-05-10Padmanabh P. BhattSr. VP of IP, CSOSell20,000.0049.88997,544.0012,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-05-11Padmanabh P. BhattSr. VP of IP, CSOSell20,000.0052.031,040,558.0012,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-06-21Padmanabh P. BhattSr. VP of IP, CSOBuy7,205.009.1365,781.6514,705.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918041853/0001104659-18-041853-index.htm
2018-05-15Padmanabh P. BhattSr. VP of IP, CSOBuy7,500.009.1368,475.0015,000.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918033849/0001104659-18-033849-index.htm
2020-07-13Frederick M. HudsonDirectorSell920.0024.4422,484.8018,041.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920083754/0001104659-20-083754-index.htm
2018-05-11Padmanabh P. BhattSr. VP of IP, CSOBuy10,882.009.24100,549.6818,382.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2020-07-13Frederick M. HudsonDirectorBuy8,750.002.5622,400.0018,961.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920083754/0001104659-20-083754-index.htm
2018-06-18Stefan K.F. SchwabeExecutive VP R&D, CMOSell60,000.0054.393,263,352.001,967.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918041086/0001104659-18-041086-index.htm
2018-06-18Stefan K.F. SchwabeExecutive VP R&D, CMOBuy20,000.007.90158,000.0021,967.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918041086/0001104659-18-041086-index.htm
2018-05-11Padmanabh P. BhattSr. VP of IP, CSOBuy11,250.009.24103,950.0023,750.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-08-20JOHN M SIEBERTDirectorBuy8,722.007.9068,903.8028,285.00https://www.sec.gov/Archives/edgar/data/1356576/000110465919012547/0001104659-19-012547-index.htm
2018-05-10Padmanabh P. BhattSr. VP of IP, CSOBuy20,000.007.90158,000.0032,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-05-11Padmanabh P. BhattSr. VP of IP, CSOBuy20,000.007.90158,000.0032,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-08-20JOHN M SIEBERTDirectorBuy7,457.009.2468,902.6835,742.00https://www.sec.gov/Archives/edgar/data/1356576/000110465919012547/0001104659-19-012547-index.htm
2018-06-28Padmanabh P. BhattSr. VP of IP, CSOSell3,402.0059.94203,899.214,393.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918043279/0001104659-18-043279-index.htm
2020-10-15GREGORY S PATRICKSr. VP, CFOSell15,000.0020.03300,507.0044,463.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920115378/0001104659-20-115378-index.htm
2020-11-05GREGORY S PATRICKSr. VP, CFOSell5,000.0023.00115,000.0044,463.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920122611/0001104659-20-122611-index.htm
2019-04-25JOHN M SIEBERTDirectorBuy10,000.009.1391,300.0045,742.00https://www.sec.gov/Archives/edgar/data/1356576/000110465919024504/0001104659-19-024504-index.htm
2020-05-08GREGORY S PATRICKSr VP, Chief Financial OfficerSell15,000.0023.14347,034.0046,057.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920059729/0001104659-20-059729-index.htm
2020-05-20GREGORY S PATRICKSr.VP, Chief Financial OfficerSell15,000.0025.03375,379.5046,057.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920064386/0001104659-20-064386-index.htm
2019-08-23Jack A. KhattarPresident, CEOBuy7,200.0026.39189,982.08465,141.00https://www.sec.gov/Archives/edgar/data/1356576/000110465919047536/0001104659-19-047536-index.htm
2019-02-27GREGORY S PATRICKSr VP, Chief Financial OfficerSell20,000.0041.53830,650.0047,896.00https://www.sec.gov/Archives/edgar/data/1356576/000110465919011559/0001104659-19-011559-index.htm
2020-07-10Jack A. KhattarPresident, CEOBuy15,625.00490,841.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920083086/0001104659-20-083086-index.htm
2020-11-05GREGORY S PATRICKSr. VP, CFOBuy5,000.0012.9864,900.0049,463.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920122611/0001104659-20-122611-index.htm
2020-07-27Jack A. KhattarPresident, CEOBuy15,625.00506,466.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920087366/0001104659-20-087366-index.htm
2020-02-21Carrolee BarlowDirectorBuy5,211.0023.99125,011.895,211.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920024853/0001104659-20-024853-index.htm
2020-02-21GEORGES GEMAYELDirectorBuy5,211.0023.99125,011.895,211.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920024851/0001104659-20-024851-index.htm
2019-06-20JOHN M SIEBERTDirectorBuy10,000.009.1391,300.0055,742.00https://www.sec.gov/Archives/edgar/data/1356576/000110465919037264/0001104659-19-037264-index.htm
2018-07-02GREGORY S PATRICKVP, Chief Financial OfficerSell35,000.0056.631,981,913.5055,975.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918043825/0001104659-18-043825-index.htm
2020-10-15GREGORY S PATRICKSr. VP, CFOBuy15,000.0012.98194,700.0059,463.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920115378/0001104659-20-115378-index.htm
2020-02-21JOHN M SIEBERTDirectorBuy5,211.0023.99125,011.8960,953.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920024846/0001104659-20-024846-index.htm
2020-05-08GREGORY S PATRICKSr VP, Chief Financial OfficerBuy15,000.009.13136,950.0061,057.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920059729/0001104659-20-059729-index.htm
2020-05-20GREGORY S PATRICKSr.VP, Chief Financial OfficerBuy15,000.0012.98194,700.0061,057.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920064386/0001104659-20-064386-index.htm
2018-06-18Stefan K.F. SchwabeExecutive VP R&D, CMOBuy40,000.009.24369,600.0061,967.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918041086/0001104659-18-041086-index.htm
2019-02-27GREGORY S PATRICKSr VP, Chief Financial OfficerBuy20,000.009.13182,600.0067,896.00https://www.sec.gov/Archives/edgar/data/1356576/000110465919011559/0001104659-19-011559-index.htm
2018-05-11Padmanabh P. BhattSr. VP of IP, CSOSell16,250.0055.23897,542.757,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-05-11Padmanabh P. BhattSr. VP of IP, CSOSell10,882.0057.90630,067.807,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-05-15Padmanabh P. BhattSr. VP of IP, CSOSell368.0057.9321,316.627,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918033849/0001104659-18-033849-index.htm
2018-06-21Padmanabh P. BhattSr. VP of IP, CSOSell7,205.0060.00432,323.067,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918041853/0001104659-18-041853-index.htm
2018-07-02GREGORY S PATRICKVP, Chief Financial OfficerBuy20,000.009.24184,800.0075,975.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918043825/0001104659-18-043825-index.htm
2018-06-28Padmanabh P. BhattSr. VP of IP, CSOBuy295.009.132,693.357,795.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918043279/0001104659-18-043279-index.htm
2018-05-15Padmanabh P. BhattSr. VP of IP, CSOBuy368.009.243,400.327,868.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918033849/0001104659-18-033849-index.htm
2018-07-02GREGORY S PATRICKVP, Chief Financial OfficerBuy15,000.009.13136,950.0090,975.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918043825/0001104659-18-043825-index.htm
2020-02-21CHARLES W III NEWHALLDirectorBuy5,211.0023.99125,011.8997,509.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920024891/0001104659-20-024891-index.htm